Updated: Aug 4, 2008
Ovarian torsion (adnexal torsion) is an infrequent but significant cause of acute lower abdominal pain in women. The clinical presentation is often nonspecific with few distinctive physical findings, commonly resulting in delay in diagnosis and surgical management.
Ovarian torsion classically occurs unilaterally in a pathologically enlarged ovary. The irregularity of the ovary likely creates a fulcrum around which the oviduct revolves. The process can involve the ovary alone but more commonly affects both the ovary and the oviduct (adnexal torsion). Approximately 60% of torsion occurs on the right side.
Multiple factors have been found to be responsible for the development of ovarian torsion. Although torsion may rarely occur in normal adnexa, it more frequently arises from one of many anatomic changes. Torsion of a normal ovary is most common among young children, in whom developmental abnormalities such as excessively long fallopian tubes or absent mesosalpinx may be responsible. In fact, less than half of torsed ovaries in pediatric patients involve cysts, teratomas, or other masses. During early pregnancy, the presence of an enlarged corpus luteum cyst likely predisposes the ovary to torsion. Women undergoing induction of ovulation for infertility carry an even greater risk, as numerous theca lutein cysts significantly expand the ovarian volume.
Ovarian tumors, both benign and malignant, are implicated in 50-60% of cases of torsion. Involved masses are nearly all greater than 4-6 cm, although torsion is possible with smaller masses.
Studies reveal that ovarian torsion is the fifth most common gynecologic surgical emergency accounting for 2.7% of cases of acute gynecologic complaints in one series.
Ovarian torsion is encountered more often in women who have had ovarian stimulation, which likely accounts for a small increased incidence in developed countries.
Most patients with ovarian torsion have a delayed diagnosis, often resulting in infarction and necrosis of the ovary. The ovarian salvage rate has been reported below 10% in adults but as high as 27% in a study among pediatric patients1 . Although it is unlikely that the loss of a single ovary results in significantly reduced fertility and no cases of death have been reported due to ovarian torsion, early diagnosis allows for conservative laparoscopic treatment and reduction in complications.
Ovarian torsion applies strictly to the female sex.
Ovarian torsion can occur at any age, but most cases occur in the early reproductive years. Approximately 17% of cases have been found to occur in premenarchal or postmenopausal women.
The physical examination, like the history, is typically nonspecific and is highly variable.
| Appendicitis, Acute | Ovarian Cysts |
| Diverticular Disease | Pelvic Inflammatory Disease |
| Endometriosis | Pregnancy, Ectopic |
| Mesenteric Ischemia | Pregnancy, Urinary Tract Infections |
| Obstruction, Large Bowel | Renal Calculi |
| Obstruction, Small Bowel | Urinary Tract Infection, Female |
Ovarian tumor
Tubal ovarian abscess
Ureteral calculi
Perforated colonic carcinoma
Prehospital care of a patient presenting with ovarian torsion includes assessing vital signs and establishing an intravenous line if the patient appears hypotensive or tachycardic, as alternative emergent diagnoses must be considered.
Pain medication may be given to a patient who presents with abdominal pain that is suspected to be from ovarian torsion. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids is acceptable.
Pain control is essential to quality patient care and should not be delayed pending surgical or gynecologic evaluation.
Inhibits prostaglandin synthesis by decreasing the activity of the enzyme, cyclooxygenase, which results in decreased formation of prostaglandin precursors.
30-60 mg IM initially followed by 15-30 mg q6h prn; not to exceed 5 d of treatment
Not established; recommended dose is 0.4-1 mg/kg IM once
Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; closely monitor PT (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding; do not administer into CNS
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases risk of acute renal failure in patients with preexisting renal disease or compromised renal perfusion; low WBC counts (rare) usually return to normal during ongoing therapy; discontinue therapy if persistent leukopenia, granulocytopenia, or thrombocytopenia occur; perform ophthalmologic studies in patients who develop eye complaints during therapy (effects include blurred or diminished vision, scotomata, changes in color vision, corneal deposits, and retinal disturbances, including macula degeneration); discontinue therapy if ocular changes are noted
DOC for narcotic analgesia because of reliable and predictable effects, safety profile, and ease of reversibility with naloxone.
Morphine sulfate administered IV may be dosed in a number of ways and is commonly titrated until the desired effect is obtained.
2-10 mg IV/IM; titrate to pain relief
0.1 mg/kg IV/IM
Phenothiazines may antagonize the analgesic effects of opiate agonists; coadministration of tricyclic antidepressants, MAOIs, and other CNS depressants may potentiate the adverse effects
Documented hypersensitivity; hypotension; potentially compromised airway with uncertain rapid airway control
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Avoid in hypotension, respiratory depression, nausea, emesis, constipation, and urinary retention; caution in atrial flutter and other supraventricular tachycardias; has vagolytic action and may increase ventricular response rate
These agents are useful in the treatment of nausea associated with the clinical symptoms of ovarian torsion. Some antiemetics also have sedative effects.
May relieve nausea and vomiting by blocking postsynaptic mesolimbic dopamine receptors through anticholinergic effects and depressing reticular activating system. In addition to antiemetic effects, has the advantage of augmenting hypoxic ventilatory response, acting as a respiratory stimulant at high altitude.
10 mg PO/IM tid/qid; not to exceed 40 mg/d
2.5-10 mg IV q3-4h prn; not to exceed 10 mg/dose or 40 mg/d
25 mg PR bid
2.5 mg PO/PR q8h or 5 mg q12h prn; not to exceed 15 mg/d
0.1-0.15 mg/kg/dose IM; change to PO as soon as possible
IV dosing is not recommended for children
Coadministration with other CNS depressants or anticonvulsants may cause additive effects; with epinephrine may cause hypotension
Documented hypersensitivity; bone marrow suppression; narrow-angle glaucoma; severe liver or cardiac disease
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Drug-induced Parkinson syndrome or pseudoparkinsonism occurs frequently; akathisia is most common extrapyramidal reaction in elderly persons; lowers seizure threshold; caution with history of seizures
Blocks dopamine receptors in the chemoreceptor trigger zone of CNS.
10-20 mg PO tid/qid for 7 d
1-2 mg/kg PO tid/qid for 7 d
Opiate analgesics may increase metoclopramide toxicity in CNS
Documented hypersensitivity; pheochromocytoma; GI hemorrhage; obstruction or perforation of bowels; seizure disorders
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Caution in history of mental illness and Parkinson disease or other movement disorder
Anders JF, Powell EC. Urgency of evaluation and outcome of acute ovarian torsion in pediatric patients. Arch Pediatr Adolesc Med. Jun 2005;159(6):532-5. [Medline].
Bellah RD, Griscom NT. Torsion of normal uterine adnexa before menarche: CT appearance. AJR Am J Roentgenol. Jan 1989;152(1):123-4. [Medline].
Bider D, Ben-Rafael Z, Goldenberg M. Pregnancy outcome after unwinding of twisted ischaemic-haemorrhagic adnexa. Br J Obstet Gynaecol. Apr 1989;96(4):428-30. [Medline].
Bider D, Mashiach S, Dulitzky M, et al. Clinical, surgical and pathologic findings of adnexal torsion in pregnant and nonpregnant women. Surg Gynecol Obstet. Nov 1991;173(5):363-6. [Medline].
Canning DA. Ovarian torsion: to pex or not to pex? Case report and review of the literature. J Urol. Apr 2005;173(4):1364. [Medline].
Cappell MS, Friedel D. Abdominal pain during pregnancy. Gastroenterol Clin North Am. Mar 2003;32(1):1-58. [Medline].
Germain M, Rarick T, Robins E. Management of intermittent ovarian torsion by laparoscopic oophoropexy. Obstet Gynecol. Oct 1996;88(4 Pt 2):715-7. [Medline].
Graif M, Itzchak Y. Sonographic evaluation of ovarian torsion in childhood and adolescence. AJR Am J Roentgenol. Mar 1988;150(3):647-9. [Medline].
Hibbard LT. Adnexal torsion. Am J Obstet Gynecol. Jun 15 1985;152(4):456-61. [Medline].
Houry D, Abbott JT. Ovarian torsion: a fifteen-year review. Ann Emerg Med. Aug 2001;38(2):156-9. [Medline].
Kamin RA, Nowicki TA, Courtney DS, Powers RD. Pearls and pitfalls in the emergency department evaluation of abdominal pain. Emerg Med Clin North Am. Feb 2003;21(1):61-72, vi. [Medline].
Koonings PP, Grimes DA. Adnexal torsion in postmenopausal women. Obstet Gynecol. Jan 1989;73(1):11-2. [Medline].
Lambert MJ, Villa M. Gynecologic ultrasound in emergency medicine. Emerg Med Clin North Am. Aug 2004;22(3):683-96. [Medline].
Lawrence LL. Unusual presentations in obstetrics and gynecology. Emerg Med Clin North Am. Aug 2003;21(3):649-65. [Medline].
Lee EJ, Kwon HC, Joo HJ. Diagnosis of ovarian torsion with color Doppler sonography: depiction of twisted vascular pedicle. J Ultrasound Med. Feb 1998;17(2):83-9. [Medline].
Mazouni C, Bretelle F, Menard JP, et al. [Diagnosis of adnexal torsion and predictive factors of adnexal necrosis]. Gynecol Obstet Fertil. Mar 2005;33(3):102-6. [Medline].
Oelsner G, Shashar D. Adnexal torsion. Clin Obstet Gynecol. Sep 2006;49(3):459-63. [Medline].
Schlaff WD, Lund KJ, McAleese KA, Hurst BS. Diagnosing ovarian torsion with computed tomography. A case report. J Reprod Med. Sep 1998;43(9):827-30. [Medline].
Shih S, Vetto JT, Berek JS, et al. Adnexal torsion. An unusual cause of abdominal pain in postmenopausal women. Am Surg. May 1991;57(5):327-9. [Medline].
Sommerville M, Grimes DA, Koonings PP, Campbell K. Ovarian neoplasms and the risk of adnexal torsion. Am J Obstet Gynecol. Feb 1991;164(2):577-8. [Medline].
Stenchever. Comprehensive Gynecology. 2001:507-520.
Warner MA, Fleischer AC, Edell SL, et al. Uterine adnexal torsion: sonographic findings. Radiology. Mar 1985;154(3):773-5. [Medline].
Webb EM, Green GE, Scoutt LM. Adnexal mass with pelvic pain. Radiol Clin North Am. Mar 2004;42(2):329-48. [Medline].
adnexal torsion, abdominal pain, ovaries, fallopian tubes, mesosalpinx, ovarian torsion, lower abdominal pain in women, enlarged ovary, ovarian tumor, dermoid tumor, elongated fallopian tube, ovarian enlargement, ovarian cyst
Erik D Schraga, MD, Consulting Staff, Department of Emergency Medicine, Mills-Peninsula Emergency Medical Associates; Consulting Staff, Permanente Medical Group, Kaiser Permanente, Santa Clara Medical Center
Disclosure: Nothing to disclose.
Michelle Blanda, MD, Chair, Department of Emergency Medicine, Summa Health System; Professor of Emergency Medicine, Northeastern Ohio Universities College of Medicine
Michelle Blanda, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Jerome FX Naradzay, MD, FACEP, Medical Director, Consulting Staff, Department of Emergency Medicine, Maria Parham Hospital; Medical Examiner, Vance County, North Carolina
Jerome FX Naradzay, MD, FACEP is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Mark Zwanger, MD, MBA, Assistant Professor, Department of Emergency Medicine, Thomas Jefferson University
Mark Zwanger, MD, MBA is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and American Medical Association
Disclosure: Nothing to disclose.
John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Pamela L Dyne, MD, Associate Professor, Program Director, Department of Medicine, Division of Emergency Medicine, University of California at Los Angeles School of Medicine
Pamela L Dyne, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)